To investigate the possible association of DUS1L expression with cancer progression, the survival probabilities of glioma patients with higher and lower DUS1L mRNA expression levels were compared using data in the Human Protein Atlas database31. The gene discussed is DUS1L; the disease is central nervous system cancer.